Follow
Pieralessandro Lasalvia
Pieralessandro Lasalvia
MD, Chief technical officer, NeuroEconomix, Bogota, Colomiba
Verified email at javeriana.edu.co
Title
Cited by
Cited by
Year
High-protein hypocaloric vs normocaloric enteral nutrition in critically ill patients: a randomized clinical trial
S Rugeles, LG Villarraga-Angulo, A Ariza-Gutiérrez, S Chaverra-Kornerup, ...
Journal of critical care 35, 110-114, 2016
1022016
Pen devices for insulin self-administration compared with needle and vial: systematic review of the literature and meta-analysis
P Lasalvia, JE Barahona-Correa, DM Romero-Alvernia, S Gil-Tamayo, ...
Journal of diabetes science and technology 10 (4), 959-966, 2016
662016
Sleep disturbances, academic performance, depressive symptoms and substance use among medical students in Bogota, Colombia
JE Barahona-Correa, JD Aristizabal-Mayor, P Lasalvia, AJ Ruiz, ...
Sleep Science 11 (4), 260, 2018
542018
Estimación de la prevalencia de EPOC en Colombia a partir del Registro Individual de Prestaciones de Servicios de Salud (RIPS)
YG Rojas, CAT Duque, M del Carmen Figueredo, F Hernández, ...
Revista Colombiana de Neumología 31 (1), 2019
382019
Burden of Disease Attributable to Obesity and Overweight in Colombia
Y Gil-Rojas, A Garzón, F Hernández, B Pacheco, D González, J Campos, ...
Value in health regional issues 20, 66-72, 2019
302019
International experiences in multicriteria decision analysis (MCDA) for evaluating orphan drugs: a scoping review
P Lasalvia, L Prieto-Pinto, M Moreno, J Castrillón, G Romano, ...
Expert review of pharmacoeconomics & outcomes research 19 (4), 409-420, 2019
262019
Cost-Effectiveness of Carbetocin Versus Oxytocin For Prevention of Postpartum Hemorrhage Resulting From Uterine Atony in High-Risk Women in Colombia
Y Gil-Rojas, P Lasalvia, F Hernández, C Castañeda-Cardona, D Rosselli
Value in Health 21, S144, 2018
26*2018
Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia
Y Gil-Rojas, P Lasalvia, F Hernández, C Castañeda-Cardona, D Rosselli
Revista Brasileira de Ginecologia e Obstetrícia 40, 242-250, 2018
252018
Postictal neurogenic pulmonary edema: Case report and brief literature review
OMR Osorio, JFA Camacho, DS Briceño, P Lasalvia, DN Gonzalez
Epilepsy & behavior case reports 9, 49-50, 2018
192018
Efficacy and safety of dabrafenib–trametinib in the treatment of unresectable advanced/metastatic melanoma with BRAF‐V600 mutation: A systematic review and network meta‐analysis
N Garzón‐Orjuela, L Prieto‐Pinto, P Lasalvia, D Herrera, J Castrillón, ...
Dermatologic therapy 33 (2), e13145, 2020
162020
Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia
Y Gil-Rojas, A Garzón, P Lasalvia, F Hernández, C Castañeda-Cardona, ...
Value in health regional issues 20, 79-85, 2019
122019
Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia
P Lasalvia, F Hernández, C Castañeda-Cardona, JA Cuestas, D Rosselli
Value in Health Regional Issues 23, 13-18, 2020
112020
How Much Does it Cost to Train a Physician in Colombia?
Y Gil-Rojas, S Gil-Tamayo, JD Mosos, F Hernández, ...
Revista Ciencias de la Salud 16 (2), 219-236, 2018
112018
Cost Effectiveness of Dulaglutide Compared with Liraglutide and Glargine in Type 2 Diabetes Mellitus Patients in Colombia
P Lasalvia, L Baquero, M Otálora-Esteban, C Castañeda-Cardona, ...
Value in health regional issues 14, 35-40, 2017
112017
Quality of life in refractory generalized myasthenia gravis: A rapid review of the literature
N Garzón-Orjuela, L van der Werf, LC Prieto-Pinto, P Lasalvia, ...
Intractable & Rare Diseases Research 8 (4), 231-238, 2019
102019
Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia
Y Gil-Rojas, P Lasalvia, A Garcia
Expert Review of Pharmacoeconomics & Outcomes Research 22 (4), 655-663, 2022
72022
Incremental cost-effectiveness analysis of tyrosine kinase inhibitors in advanced non-small cell lung cancer with mutations of the epidermal growth factor receptor in Colombia
P Lasalvia, F Hernández, Y Gil-Rojas, D Rosselli
Expert Review of Pharmacoeconomics & Outcomes Research 21 (4), 821-827, 2021
72021
The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008–2019
M Pawaskar, Y Gil-Rojas, CI Parellada, A Rey-Velasco, C Beltrán, ...
Vaccine 40 (35), 5095-5102, 2022
62022
Trends in Varicella Burden of Disease Following Introduction of Routine Childhood Varicella Vaccination in Argentina: A 12-Year Time Series Analysis
N Giglio, P Lasalvia, M Pawaskar, CI Parellada, YG Rojas, P Micone, ...
Vaccines 10 (7), 1151, 2022
62022
Atosiban efficacy and safety in pregnant women with threatened preterm delivery: systematic review of the literature with network meta-analysis
L Salazar-Castelblanco, P Restrepo-Jiménez, P Lasalvia, ...
Revista Colombiana de Obstetricia y Ginecología 69 (4), 270-302, 2018
6*2018
The system can't perform the operation now. Try again later.
Articles 1–20